These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 35802628)
21. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers. Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700 [TBL] [Abstract][Full Text] [Related]
22. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults. Ten Kate M; Sanz-Arigita EJ; Tijms BM; Wink AM; Clerigue M; Garcia-Sebastian M; Izagirre A; Ecay-Torres M; Estanga A; Villanua J; Vrenken H; Visser PJ; Martinez-Lage P; Barkhof F Neurobiol Aging; 2016 Feb; 38():14-20. PubMed ID: 26827639 [TBL] [Abstract][Full Text] [Related]
23. APOE4 allele-specific associations between diet, multimodal biomarkers, and cognition among Puerto Rican adults in Massachusetts. Guan Y; Cheng CH; Bellomo LI; Narain S; Bigornia SJ; Garelnabi MO; Scott T; Ordovás JM; Tucker KL; Bhadelia R; Koo BB Front Aging Neurosci; 2023; 15():1285333. PubMed ID: 38035273 [TBL] [Abstract][Full Text] [Related]
24. Brain myelin water fraction is associated with APOE4 allele status in patients with cognitive impairment. Park M; Lee HP; Kim J; Kim DH; Moon Y; Moon WJ J Neuroimaging; 2022 May; 32(3):521-529. PubMed ID: 34964524 [TBL] [Abstract][Full Text] [Related]
25. Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife. Dounavi ME; Mak E; Swann P; Low A; Muniz-Terrera G; McKeever A; Pope M; Williams GB; Wells K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie K; Su L; Ritchie CW; O'Brien JT J Cereb Blood Flow Metab; 2023 Oct; 43(10):1672-1684. PubMed ID: 37132287 [TBL] [Abstract][Full Text] [Related]
26. Sex difference in the association of APOE4 with cerebral glucose metabolism in older adults reporting significant memory concern. Jiang L; Lin H; Alzheimer's Disease Neuroimaging Initiative ; Chen Y Neurosci Lett; 2020 Mar; 722():134824. PubMed ID: 32044391 [TBL] [Abstract][Full Text] [Related]
27. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J; Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226 [TBL] [Abstract][Full Text] [Related]
28. The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age. Kim J; Park S; Yoo H; Jang H; Kim Y; Kim KW; Jang YK; Lee JS; Kim ST; Kim S; Lee JM; Ki CS; Na DL; Seo SW; Kim HJ J Alzheimers Dis; 2018; 61(4):1377-1385. PubMed ID: 29376853 [TBL] [Abstract][Full Text] [Related]
29. Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene. Traversy MT; Vandal M; Tremblay C; Tournissac M; Giguère-Rancourt A; Bennett AD; Calon F Psychoneuroendocrinology; 2017 Mar; 77():203-210. PubMed ID: 28088659 [TBL] [Abstract][Full Text] [Related]
30. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2. Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162 [TBL] [Abstract][Full Text] [Related]
31. Immediate effects of a single session of physical exercise on cognition and cerebral blood flow: A randomized controlled study of older adults. Olivo G; Nilsson J; Garzón B; Lebedev A; Wåhlin A; Tarassova O; Ekblom M; Lövdén M Neuroimage; 2021 Jan; 225():117500. PubMed ID: 33169699 [TBL] [Abstract][Full Text] [Related]
32. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers. Chételat G; Fouquet M Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463 [TBL] [Abstract][Full Text] [Related]
33. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment. Low A; Ng KP; Chander RJ; Wong B; Kandiah N J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121 [TBL] [Abstract][Full Text] [Related]
34. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. Honea RA; Vidoni E; Harsha A; Burns JM J Alzheimers Dis; 2009; 18(3):553-64. PubMed ID: 19584447 [TBL] [Abstract][Full Text] [Related]
35. Biomarker Responses to Acute Exercise and Relationship with Brain Blood Flow. Morris JK; Kueck PJ; Kemna RE; Green ZD; John CS; Winter M; Billinger SA; Vidoni ED J Alzheimers Dis; 2024; 97(1):283-292. PubMed ID: 38108352 [TBL] [Abstract][Full Text] [Related]
36. Sex-Dependent Effects of Cardiometabolic Health and Subramaniapillai S; Schindler LS; Redmond P; Bastin ME; Wardlaw JM; Valdés Hernández M; Maniega SM; Aribisala B; Westlye LT; Coath W; Groves J; Cash DM; Barnes J; James SN; Sudre CH; Barkhof F; Richards M; Corley J; Russ TC; Cox SR; Schott JM; Cole JH; de Lange AG Neurology; 2024 Sep; 103(6):e209744. PubMed ID: 39173100 [TBL] [Abstract][Full Text] [Related]
37. Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease. Wroolie T; Roat-Shumway S; Watson K; Reiman E; Rasgon N J Alzheimers Dis; 2020; 75(3):903-910. PubMed ID: 32390619 [TBL] [Abstract][Full Text] [Related]
38. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease. Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337 [TBL] [Abstract][Full Text] [Related]
39. Hippocampal blood flow rapidly and preferentially increases after a bout of moderate-intensity exercise in older adults with poor cerebrovascular health. Palmer JA; Morris JK; Billinger SA; Lepping RJ; Martin L; Green Z; Vidoni ED Cereb Cortex; 2023 Apr; 33(9):5297-5306. PubMed ID: 36255379 [TBL] [Abstract][Full Text] [Related]
40. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC; Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]